Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study of Different Sequences of Cilta-cel, Talquetamab in Combination With Daratumumab and Teclistamab in Combination With Daratumumab Following Induction With Daratumumab, Bortezomib, Lenalidomide and Dexamethasone in Participants With Standard-risk Newly Diagnosed Multiple Myeloma

Janssen Research & Development, LLC · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
multiple-myeloma
multiple myeloma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 811473
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.